Klinik Atölye

Karaciğer: fokal lezyonlar · Taklitçi · Orta öncelik

Arterioportal şant ve fokal hiperperfüzyon

Arterioportal shunt and focal hyperperfusion

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez.

Arterioportal şant ve fokal hiperperfüzyon: yayımlanmış olgu görüntüsü, aksiyel kesit

5 adım

Görüntü: Hellerhoff, “Arteriovenoeser Shunt Leber - 63jw - CT axial arteriell und portalvenoes”, Wikimedia Commons · CC BY-SA 3.0. Değişiklik: kırpıldı, yeniden boyutlandırıldı, odak işaretleri eklendi.

Özet

Arterioportal şantta arteriyel kan, normal sinüzoidal dolaşımı kısmen atlayarak portal ven dalına ulaşır; siroz, tümör, travma veya girişim sonrasında gelişebilir. Dinamik BT'de erken portal ven opasifikasyonu ve beslediği alanda geçici arteriyel hiperatenüasyon görülebilir. Bu iki bulgunun birlikte aranması, tek başına parlak parankimi hepatoselüler karsinom sayma riskini azaltır. Şantın altında yatan portal ven tıkanıklığı veya tümör atlanırsa, yalancı odak yorumunun ötesinde klinik olarak önemli damar hastalığı da gözden kaçabilir.

Faz ve pencere

Arteriyel tanısal
Hepatik vasküler malformasyonlarda BT'de portal venin erken görüntülenmesi görülebilir. Periferik şantta düz sınırlı kama/koni biçimli parankim hiperatenüasyonu eşlik edebilir; küçük şantlarda erken damar bulgusu seçilmeyebilir.
Portal tanısal
Portal venöz fazda kama biçimli parankim hiperkontrastlanması komşu karaciğerle eşitlenebilir; hepatik perfüzyon bozukluğu alanları bu fazda izoatenüöz veya hafif hipertenüöz görünebilir.

Önerilen pencereler: Anjiyo (G 600 / M 150), Karaciğer (G 150 / M 30), Batın (G 400 / M 50).

BT bulguları

  • Hepatik vasküler malformasyonlarda BT'de portal ven erken görüntülenebilir.
  • Beslenen bölgede periferik, homojen, düz kenarlı kama ya da koni biçimli arteriyel hiperatenüasyon.
  • Üç boyutlu dağılımda odağın sivri ucunun hilusa yönelmesi ve damar alanı biçimini alması.
  • Portal fazda parankim atenüasyonlarının yakınlaşması; geçici odakta tümöre özgü yıkanma olmaması.
  • Şant odağındaki küçük damarlar görüntülemede sınırlı çözünürlük nedeniyle seçilemeyebilir.
  • Hepatik arterioportal şant altta yatan tümörle veya travma ya da girişim sonrasında ilişkili olabilir.
  • Hepatik perfüzyon bozukluğu arteriyel fazda geçici, homojen hiperatenuasyon gösterebilir.

Ölçütler ve sınıflamalar

Şantın bağlandığı damar sistemine göre
Hepatik vasküler şantlar bağlandıkları damar sistemine göre arteriyovenöz, arterioportal veya portovenöz olarak tanımlanır. Şantın derecesine bağlı olarak semptomlar ve yaşamı tehdit eden komplikasyonlar ortaya çıkabilir.

Normalde

Hepatik perfüzyon bozukluğunda arteriyel fazdaki geçici hiperatenuasyon portal fazda izoatenüöz veya hafif hipertenüöz hale gelebilir. Bu incelemede çevresel portal dalın ana portal venden önce parlaklaşıp parlaklaşmadığını ve onun komşuluğundaki parankimin aynı anda üçgen bir hiperatenüasyon gösterip göstermediğini karşılaştır.

Normal BT ile kıyasla

Aynı bölgenin, kaynak veri setinde patoloji içermediği belirtilen bir BT incelemesini kesit kesit kaydırın; organ sınırlarını açarak anatomiyi hasta görüntüsüyle karşılaştırın. Küçük rastlantısal bulgular tümüyle dışlanmamıştır.

Kaynak: TotalSegmentator v2.01 veri seti (Wasserthal ve ark., Radiology: Artificial Intelligence 2023), CC BY 4.0, vaka s0541; organ sınırları veri setinin otomatik segmentasyonundan, birleştirilerek sadeleştirildi. Görüntüler 2,5 mm kesit aralığına yeniden örneklendi.

Ayırıcı tanı

Hepatoselüler karsinom
kitle biçimli arteriyel kontrastlanma ve portal/geç fazda yıkanma; bazen tümör trombüsü gösterir.
Fokal nodüler hiperplazi
arteriyel fazda hiperkontrastlanan kitle biçimli lezyon olup, portal venöz ve gecikmiş fazlarda çevre parankimle izoattenüe olur; tipik merkezî skar BT'de sıklıkla görülemez.
Portal ven trombozu
lümen içinde dolum kusuru ve akım havzasında olası kollateraller bulunur; şant bulgusu trombozun sebebini açıklayabilir.
Hepatik arteriyovenöz malformasyon
belirgin besleyici arter ve erken venöz drenajla daha geniş damar ağı oluşturabilir.
Hepatik damar varyasyonları
arteriyel kan akımının karaciğer segmentleri arasında yeniden dağılımına bağlı perfüzyon farkı oluşturabilir.

Tuzaklar

  • Hepatik arterioportal şantta portal venin erken görüntülenmesi görülebilir; eşlik eden altta yatan karaciğer anomalileri dikkatle değerlendirilmelidir.
  • Periferik şant odağındaki küçük damarlar sınırlı görüntüleme çözünürlüğü nedeniyle seçilemeyebilir.
  • Sirotik karaciğerde nontümöral arterioportal şantlar fokal hipervasküler lezyonları taklit edebilir; yalnız arteriyel hiperkontrastlanmaya dayanarak bu alanı HCC olarak değerlendirme.
  • Hepatik arterioportal fistül travma veya girişim sonrasında gelişebilir; görüntüleri değerlendirirken işlem öyküsünü göz önünde bulundur.

Kendini dene

  1. Kontrastlı BT’de hepatik perfüzyon bozukluğu arteriyel fazda nasıl görünebilir?

    Cevabı göster

    Geçici, kama biçimli homojen hiperatenuasyon. Hepatik perfüzyon bozukluğu, arteriyel fazda geçici, kama biçimli ve homojen hiperatenuasyon alanı şeklinde görülebilir.

  2. Sirozlu hastada kitle biçimli bir nodülde arteriyel fazda çevresel olmayan hiperkontrastlanma ve portal venöz fazda çevre karaciğere göre yıkanma izleniyor. Hangi tanı daha olasıdır?

    Cevabı göster

    Küçük HCC. Siroz zemininde arteriyel faz hiper-kontrastlanması ve portal venöz ya da geç faz yıkanma, HCC değerlendirmesinde kullanılan temel görüntüleme özellikleridir. Arteriyel faz hiperkontrastlanması ve yıkanma HCC’ye özgü değildir; bazı hipervasküler benign ve malign karaciğer lezyonları da bu paterni gösterebilir.

İlgili konular

Kaynaklar

Bu sayfadaki 40 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 26 cümle bu karşılaştırmada düzeltildi (2026-10-09).

  1. Clinical applications of 4D flow magnetic resonance imaging in hepatic vascular disorders: practical biomarkers, protocol design, and translational implementationpmc.ncbi.nlm.nih.gov
  2. Hepatic focal nodular hyperplasia after liver transplantation: case report and review of literaturepmc.ncbi.nlm.nih.gov
  3. Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasiapmc.ncbi.nlm.nih.gov
  4. CIRSE 2022 Book of Abstractspmc.ncbi.nlm.nih.gov
  5. Hepatic artery pseudoaneurysm-the Mayo Clinic experience and literature review.pubmed.ncbi.nlm.nih.gov
  6. Hepatic Hemangioma: Review of Imaging and Therapeutic Strategies.pubmed.ncbi.nlm.nih.gov
  7. Angioembolization of Post-traumatic Intrahepatic Arterioportal Fistula Presenting With Portal Hypertension.pubmed.ncbi.nlm.nih.gov
  8. CT and MRI imaging and interpretation of hepatic arterioportal shunts.pubmed.ncbi.nlm.nih.gov
  9. Imaging findings of mimickers of hepatocellular carcinoma.pubmed.ncbi.nlm.nih.gov
  10. Early cross-sectional imaging following open and laparoscopic cholecystectomy: a primer for radiologists.pubmed.ncbi.nlm.nih.gov
  11. A case of hepatic segmental atrophy mimicking spontaneously necrotized hepatocellular carcinoma.pubmed.ncbi.nlm.nih.gov
  12. Washout on Contrast-Enhanced Ultrasound of Benign Focal Liver Lesions-A Review on Its Frequency and Possible Causes.pubmed.ncbi.nlm.nih.gov
  13. Benign and malignant focal liver lesions displaying rim arterial phase hyperenhancement on CT and MRI.pubmed.ncbi.nlm.nih.gov
  14. Portal Vein Damage after DEB-TACE and Lipiodol-TACE: Based on Evaluation by Computed Tomography during Arterial Portography.pubmed.ncbi.nlm.nih.gov
  15. Current Imaging Diagnosis of Hepatocellular Carcinoma.pubmed.ncbi.nlm.nih.gov
  16. Transarterial and Transhepatic Endovascular Intervention to Alleviate Portal Hypertension Secondary to Arterioportal Fistula in a Trisomy 21 Infant.pubmed.ncbi.nlm.nih.gov
  17. Acute portal vein thrombosis postimage-guided liver biopsy in common variable immunodeficiency.pubmed.ncbi.nlm.nih.gov
  18. Case Report: Acute superior mesenteric vein and portal vein thrombosis complicated by small intestinal necrosis: a case of successful endovascular treatment.pubmed.ncbi.nlm.nih.gov
  19. Imaging features, diagnosis, and clinical management of hepatic involvement in hereditary hemorrhagic telangiectasia: a case series report and literature review.pubmed.ncbi.nlm.nih.gov
  20. Hepatic perfusion disorders: etiopathogenesis and related diseases.pubmed.ncbi.nlm.nih.gov
  21. The Washout of Hepatocellular Carcinoma at Portal Venous Phase vs. Equilibrium Phase: Radiological and Clinicopathological Implication.pubmed.ncbi.nlm.nih.gov
  22. FOLFOX-HAIC Plus Lenvatinib and Tislelizumab in Advanced Hepatocellular Carcinoma with Arteriovenous Fistulae: A Real-World Study.pubmed.ncbi.nlm.nih.gov
  23. Radiologic Interventions for Gastrointestinal Bleeding.pubmed.ncbi.nlm.nih.gov
  24. Contrast-enhanced ultrasound LI-RADS nonradiation treatment response assessment: applications, challenges, and future directions.pubmed.ncbi.nlm.nih.gov
  25. Clinical features and diagnostic imaging of cholangiolocellular carcinoma compared with other primary liver cancers: a surgical perspective.pubmed.ncbi.nlm.nih.gov
  26. Long-term safety and effectiveness of the "OptEase" vena cava filter.pubmed.ncbi.nlm.nih.gov
  27. High-affinity alphavbeta3 integrin targeted optical probe as a new imaging biomarker for early atherosclerosis: initial studies in Watanabe rabbits.pubmed.ncbi.nlm.nih.gov
  28. Effect of metformin on insulin resistance in adults with type 1 diabetes: a 26-week randomized double-blind clinical trial.pubmed.ncbi.nlm.nih.gov
  29. The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial.pubmed.ncbi.nlm.nih.gov
  30. Detection of hepatocellular carcinoma feeding vessels: MDCT angiography with 3D reconstruction versus digital subtraction angiography.pubmed.ncbi.nlm.nih.gov
  31. Medical and Interventional Management of Hereditary Hemorrhagic Telangiectasia.pubmed.ncbi.nlm.nih.gov
  32. Splenic Artery Aneurysm With Arterioportal Fistula: An Unusual Cause of Portal Hypertension.pubmed.ncbi.nlm.nih.gov
  33. Coil embolization of symptomatic splenic arterioportal fistula following bariatric surgery.pubmed.ncbi.nlm.nih.gov
  34. Hepatic barrage to high-flow, intra-hepatic arteroportal fistulas requiring combined interventional approach.pubmed.ncbi.nlm.nih.gov
  35. Contrast-Enhanced Low-Mechanical-Index Endoscopic Ultrasound for the Evaluation of Focal Liver Lesions.pubmed.ncbi.nlm.nih.gov
  36. Case Report: Indocyanine green fluorescence imaging in complex focal nodular hyperplasia resection: report of two cases.pubmed.ncbi.nlm.nih.gov
  37. Liver Imaging Reporting and Data System (LI-RADS): A Comprehensive Review.pubmed.ncbi.nlm.nih.gov
  38. Computed Tomographic Findings in Dogs with Hepatic Bacterial Parenchymal Infection and Abscessation.pubmed.ncbi.nlm.nih.gov
  39. Dual-Energy CT Images: Pearls and Pitfalls.pubmed.ncbi.nlm.nih.gov
  40. Interventional Radiology in the Management of Primary Liver Malignancies.pubmed.ncbi.nlm.nih.gov
  41. Unmasking infiltrative hepatocellular carcinoma: a pictorial essay.pubmed.ncbi.nlm.nih.gov
  42. Multifocal hepatocellular carcinoma in a noncirrhotic liver: A diagnostic pitfall mimicking cholangiocarcinoma and metastatic disease.pubmed.ncbi.nlm.nih.gov
  43. Contrast-enhanced ultrasound of benign and malignant liver lesions in children.pubmed.ncbi.nlm.nih.gov
  44. Update of the risk assessment of polybrominated diphenyl ethers (PBDEs) in food.pubmed.ncbi.nlm.nih.gov
  45. Re-evaluation of the risks to public health related to the presence of bisphenol A (BPA) in foodstuffs.pubmed.ncbi.nlm.nih.gov
  46. Pseudotumoral portal cavernoma mimicking hilar cholangiocarcinoma: A diagnostic pitfall.pubmed.ncbi.nlm.nih.gov
  47. Role of Grey Scale and Color Doppler in the Diagnosis of Portal Hypertension: A Comprehensive Review.pubmed.ncbi.nlm.nih.gov
  48. Inferior Vena Cava-Atrial Anastomosis in Liver Transplant Recipient with Inferior Vena Cava Occlusion: A Case Report and Literature Review.pubmed.ncbi.nlm.nih.gov
  49. Transportal Embolization of the Dominant Outflow Vein for a Pancreatic Head Arteriovenous Malformation: A Case Report.pubmed.ncbi.nlm.nih.gov
  50. An unusual superior mesenteric arteriovenous malformation causing obscure gastrointestinal bleeding: a case report.pubmed.ncbi.nlm.nih.gov
  51. Multiple arteriovenous malformations due to liver failure: An unusual etiology.pubmed.ncbi.nlm.nih.gov
  52. Human biomarker navigator.pubmed.ncbi.nlm.nih.gov
  53. A Scoping Review on Biomarkers of Endothelial Dysfunction in Small Vessel Disease: Molecular Insights from Human Studies.pubmed.ncbi.nlm.nih.gov
  54. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective.pubmed.ncbi.nlm.nih.gov
  55. Modern Imaging Guidelines for 3-D Modeling of Pediatric Solid Tumors: A New Era of Surgical Oncology Operative Planning.pubmed.ncbi.nlm.nih.gov
  56. Evaluation of Living Liver Donors Using Dual-Contrast-Agent Magnetic Resonance Imaging (MRI) and Cholangiopancreatography (MRCP)-Technical Development.pubmed.ncbi.nlm.nih.gov
  57. Patient-specific computational fluid dynamics analysis of portal vein hemodynamics before and after balloon angioplasty following living donor liver transplantation: a proof-of-concept study.pubmed.ncbi.nlm.nih.gov
  58. Photon-counting detector CT in oncology: a new era of cancer imaging.pubmed.ncbi.nlm.nih.gov
  59. WSB.APP/PS1 mice develop age-dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits.pubmed.ncbi.nlm.nih.gov
  60. Imaging Diagnosis of Various Hepatocellular Carcinoma Subtypes and Its Hypervascular Mimics: Differential Diagnosis Based on Conventional Interpretation and Artificial Intelligence.pubmed.ncbi.nlm.nih.gov
  61. Benign focal liver lesions masquerading as primary liver cancers on MRI.pubmed.ncbi.nlm.nih.gov
  62. Hepatocellular Carcinoma: Diagnosis, Treatment Algorithms, and Imaging Appearance after Transarterial Chemoembolization.pubmed.ncbi.nlm.nih.gov
  63. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.pubmed.ncbi.nlm.nih.gov
  64. 2018 Korean Liver Cancer Association-National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma.pubmed.ncbi.nlm.nih.gov
  65. Utilisation of Objective and Subjective Image Quality Metrics to Guide Optimal Contrast Volumes for Abdominal CT.pubmed.ncbi.nlm.nih.gov
  66. Mistaken Identity: Superior Mesenteric Vein Syndrome Presenting as Superior Mesenteric Artery Syndrome.pubmed.ncbi.nlm.nih.gov
  67. A CT-Based 3D Anatomical Mapping Study of Right Posterior Portal and Hepatic Venous Patterns: Revisiting Liver Segmentation and Its Surgical Implication.pubmed.ncbi.nlm.nih.gov
  68. Iatrogenic portobiliary fistula treated with covered stent following percutaneous transhepatic biliary drainage.pubmed.ncbi.nlm.nih.gov
  69. Periportal Right Colic Artery Arising From the Ventral Aspect of the Superior Mesenteric Artery With Associated Vascular Anomalies: A Case Report.pubmed.ncbi.nlm.nih.gov
  70. Imaging Spectrum of Intrahepatic Mass-Forming Cholangiocarcinoma and Its Mimickers: How to Differentiate Them Using MRI.pubmed.ncbi.nlm.nih.gov
  71. Integrative Phytochemical, Antioxidant, and NLRP3-Linked and Anti-Inflammatory Evaluation of Salvia balansae (Aurès Chemotype): Insights Into Its Safety and Therapeutic Potential.pubmed.ncbi.nlm.nih.gov
  72. EACR 2025 Congress: Innovative Cancer Science, 16-19 June 2025.pubmed.ncbi.nlm.nih.gov
  73. Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.pubmed.ncbi.nlm.nih.gov
  74. When Cancer Clots: An Extensive Radiologic Analysis of Cancer-Associated Thromboembolism.pubmed.ncbi.nlm.nih.gov
  75. Burden of Liver Disease Among Individuals With Turner Syndrome and Klinefelter Syndrome: A Comprehensive Perspective.pubmed.ncbi.nlm.nih.gov
  76. Coagulation Abnormalities in Liver Cirrhosis: Diagnostic and Therapeutic Approaches.pubmed.ncbi.nlm.nih.gov
  77. Hepatobiliary phase imaging in HCC: revisiting diagnostic algorithms and clinical utility of gadoxetic acid-enhanced MRI across international guidelines.pubmed.ncbi.nlm.nih.gov
  78. Clinical applications of 4D flow magnetic resonance imaging in hepatic vascular disorders: practical biomarkers, protocol design, and translational implementation.pubmed.ncbi.nlm.nih.gov
  79. Current guidelines for diagnosis and management of hepatic involvement in hereditary hemorrhagic teleangiectasia.pubmed.ncbi.nlm.nih.gov
  80. Endovascular flow reduction after portal vein arterialization: a technical note.pubmed.ncbi.nlm.nih.gov
  81. Clinical efficacy of TACE using coil or gelatin sponge combined with targeted therapy in the treatment of giant hepatocellular carcinoma with arterioportal fistulas.pubmed.ncbi.nlm.nih.gov
  82. The Use of Glue as an Embolic Agent in Trauma.pubmed.ncbi.nlm.nih.gov
  83. Haemodynamic alterations associated with hepatic vascular malformations in hereditary haemorrhagic telangiectasia: A cohort study.pubmed.ncbi.nlm.nih.gov
  84. Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and PD-1 Inhibitors for Managing Arterioportal Shunt in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Retrospective Cohort Study.pubmed.ncbi.nlm.nih.gov
  85. Spontaneous hepatic arterioportal fistula in extrahepatic portal vein obstruction: Combined endovascular and surgical management.pubmed.ncbi.nlm.nih.gov
  86. Transhepatic ultrasound guided embolization as a successful novel technique in treatment of pediatric complex intrahepatic arterioportal fistula: a case report and review of the literature.pubmed.ncbi.nlm.nih.gov
  87. Case report: Congenital arterioportal fistula: An unusual cause of variceal bleeding in adults.pubmed.ncbi.nlm.nih.gov
  88. Transient hepatic intensity differences: correlations with treatment outcomes and adverse events following DEB-TACE in hepatocellular carcinoma.pubmed.ncbi.nlm.nih.gov
  89. Radiological Assessment After Pancreaticoduodenectomy for a Precision Approach to Managing Complications: A Narrative Review.pubmed.ncbi.nlm.nih.gov
  90. Imaging and radiological interventions in extra-hepatic portal vein obstruction.pubmed.ncbi.nlm.nih.gov
  91. Spontaneous bacteremia and spontaneous bacterial peritonitis share similar prognosis in patients with cirrhosis: a cohort study.pubmed.ncbi.nlm.nih.gov
  92. A safe seal: controlled flow arrest with dual balloon protection for embolisation of a large spontaneous splenic arteriovenous fistula-a case report.pubmed.ncbi.nlm.nih.gov
  93. Contrast-Enhanced CT Finding of Hot Spot Sign Secondary to Supra Hilar Mass Causing Superior Vena Cava Syndrome: A Case Report.pubmed.ncbi.nlm.nih.gov
  94. A comparison of contrast-to-noise ratio of liver tumors between dynamic contrast-enhanced CT and respiration-tracked 4D-CT for radiotherapy targeting.pubmed.ncbi.nlm.nih.gov
  95. Radioembolization: Technical Tips and Follow-Up Imaging.pubmed.ncbi.nlm.nih.gov
  96. Multimodal imaging techniques in Yttrium-90 radioembolization for hepatocellular carcinoma: a modality-oriented clinical review.pubmed.ncbi.nlm.nih.gov
  97. Adult Hepatic Infarction for Internists: A Practical Diagnostic and Management Pathway to Avoid Misdiagnosis, Unnecessary Drainage, and Delayed Vascular Recognition.pubmed.ncbi.nlm.nih.gov
  98. Local-Regional Treatment of Hepatocellular Carcinoma: A Primer for Radiologists.pubmed.ncbi.nlm.nih.gov
  99. Budd-Chiari syndrome: imaging review.pubmed.ncbi.nlm.nih.gov
  100. Assessing Venous Congestion in Acute and Chronic Heart Failure: A Review of Splanchnic, Cardiac and Pulmonary Ultrasound: Part 1: Conventional B-Mode, Colordoppler, and Vexus Protocol.pubmed.ncbi.nlm.nih.gov
  101. All You Need to Know About TACE: A Comprehensive Review of Indications, Techniques, Efficacy, Limits, and Technical Advancement.pubmed.ncbi.nlm.nih.gov
  102. PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.pubmed.ncbi.nlm.nih.gov
  103. Best practices for pediatric liver MRI: guidelines from members of the Society for Pediatric Radiology Magnetic Resonance and Abdominal Imaging Committees.pubmed.ncbi.nlm.nih.gov
  104. Infarcts and ischemia in the abdomen: an imaging perspective with an emphasis on cross-sectional imaging findings.pubmed.ncbi.nlm.nih.gov
  105. A Comprehensive Review of Transjugular Intrahepatic Portosystemic Shunt-Related Complications.pubmed.ncbi.nlm.nih.gov
  106. Incidental Findings in Pediatric Patients: How to Manage Liver Incidentaloma in Pediatric Patients.pubmed.ncbi.nlm.nih.gov
  107. Diagnostic Value of the Split-Bolus CT Protocol in Blunt Abdominal Trauma: Comparison With Standard Portal Venous Phase Imaging.pubmed.ncbi.nlm.nih.gov
  108. Contrast-Enhanced CT of the Coelom in a Female Bald Eagle (<i>Haliaeetus leucocephalus</i>): Development of a Preliminary CT-Based Anatomical Segmentation Workflow.pubmed.ncbi.nlm.nih.gov
  109. Hepatic Alveolar Echinococcosis Mimicking Perihilar Cholangiocarcinoma: A Case Report.pubmed.ncbi.nlm.nih.gov
  110. Hepatic carcinosarcoma with predominant sarcomatous component mimicking intrahepatic cholangiocarcinoma: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  111. Ultrasound imaging features of pediatric extralobar pulmonary sequestration with torsion: a retrospective observational study.pubmed.ncbi.nlm.nih.gov
  112. Multimodal imaging features to diagnose abdominal complications of sickle cell disease.pubmed.ncbi.nlm.nih.gov
  113. The Role of CEUS in the Diagnosis and Follow-Up of Pleuropulmonary Diseases and Interventional Procedures.pubmed.ncbi.nlm.nih.gov
  114. Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms.pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.